| Literature DB >> 35979838 |
Caroline Schulmeister1,2, Jason Lee3,4, Farzana Perwad3, Roger Long1, Shylaja Srinivasan1.
Abstract
Summary: Skeletal abnormalities with delayed bone age and decreased linear bone growth are commonly found in children with prolonged juvenile hypothyroidism. However, rachitic bone abnormalities have not been previously reported in children with acquired hypothyroidism. Here, we present a case of newly found rickets in an 8-year-old female with untreated acquired hypothyroidism secondary to Hashimoto's thyroiditis. Laboratory finding for abnormalities in calcium/phosphorus homeostasis and hormones that regulate skeletal health was normal. Her radiographic anomalies resolved with levothyroxine treatment alone, suggesting that hypothyroidism was the etiology of the rickets. To our knowledge, this is the first case report of rickets associated with long-standing severe acquired hypothyroidism that resolved exclusively with thyroid repletion. Learning points: Thyroid hormone plays an important role in bone mineralization. Prolonged hypothyroidism can result in rachitic bone abnormalities noted on radiographs. Hypothyroidism should be considered in the evaluation of a child with rickets.Entities:
Year: 2022 PMID: 35979838 PMCID: PMC9422259 DOI: 10.1530/EDM-22-0267
Source DB: PubMed Journal: Endocrinol Diabetes Metab Case Rep ISSN: 2052-0573
Thyroid function tests.
| Initial | 2 months | |
|---|---|---|
| Thyroid-stimulating hormone 0.5–4.30 mlU/L | >150 | 5.96 |
| Free thyroxine 0.9–1.4 ng/dL | 0.2 | 0.9 |
| Thyroperoxidase antibody < 9 IU/mL | 835 | |
| Thyroglobulin antibody < 1 IU/mL | < 1 |
Metabolic Laboratory findings.
| Initial | 1 month | 4 months | 8 months | |
|---|---|---|---|---|
| Insulin-like growth factor 1 80–307 ng/mL | 32 | 137 | ||
| Insulin-like growth factor binding protein 3 1.6–6.5 mg/L | 2.1 | 2.9 | ||
| Alkaline phosphatase 181–415 U/L | 75 | 334 | ||
| Alanine transaminase 20–50 U/L | 26 | 24 | ||
| Aspartate transaminase 17–42 U/L | 55 | 34 | ||
| Low-density lipoproteins <110 mg/dL | 172 | 83 | ||
| High-density lipoproteins >45 mg/dL | 43 | 35 | ||
| Triglycerides <75 mg/dL | 146 | 182 (not fasting) | ||
| White blood count 4.5–13.5 Thousand/μL | 4.7 | 4.6 | ||
| Hemoglobin 11.5–15.5 g/dL | 8.1 | 9.1 | ||
| Hematocrit 35–45 % | 23.3 | 28.6 | ||
| Platelet count 140–450 thousand/μL | 282 | 410 |
Figure 1(A) Radiograph of left hand at initial bone age. Bone age was 6 years 10 months at a chronological age of 8 years 7 months (−1.8 s.d.). Predicted height was 156 cm with a mid-parental height of 175 cm. (B) Enlargement of initial bone age. Arrows represent sclerosis and fraying at the epiphyses of the radius and ulna.
Bone-related laboratory findings.
| Initial | 1 month | 2 months | |
|---|---|---|---|
| Creatinine 0.30–0.60 mg/dL | 0.97 | 0.44 | |
| Calcium 8.8–10.3 mg/dL | 9.7 | 9.7 | 9.4 |
| Phosphorus 2.8–5.7 mg/dL | 5.6 | 5.1 | |
| Albumin 8–59 pg/mL | 21 | ||
| Parathyroid hormone 0.30–0.60 mg/dL | 0.45 | ||
| Vitamin D 1, 25 31–87 pg/mL | 57 | ||
| Vitamin D 25 hydroxy 30–100ng/mL | 39 | ||
| Urine calcium mg/dL | 0.9 | ||
| Urine creatinine mg/dL | 16 |
Figure 2Follow-up bone age with improvement in sclerosis and fraying after levothyroxine treatment.